TY  - GEN
AU  - Arlen,Philip M
AU  - Gulley,James L
AU  - Parker,Catherine
AU  - Skarupa,Lisa
AU  - Pazdur,Mary
AU  - Panicali,Dennis
AU  - Beetham,Patricia
AU  - Tsang,Kwong Y
AU  - Grosenbach,Douglas W
AU  - Feldman,Jarett
AU  - Steinberg,Seth M
AU  - Jones,Elizabeth
AU  - Chen,Clara
AU  - Marte,Jennifer
AU  - Schlom,Jeffrey
AU  - Dahut,William
TI  - A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer
SN  - 1078-0432
PY  - 2006///0417
KW  - Acid Phosphatase
KW  - blood
KW  - Aged
KW  - Aged, 80 and over
KW  - Androgens
KW  - physiology
KW  - Antigens
KW  - Antigens, Neoplasm
KW  - Antigens, Surface
KW  - Antineoplastic Agents, Phytogenic
KW  - therapeutic use
KW  - Cancer Vaccines
KW  - immunology
KW  - Combined Modality Therapy
KW  - Cross-Over Studies
KW  - Disease-Free Survival
KW  - Docetaxel
KW  - Glutamate Carboxypeptidase II
KW  - Glycoproteins
KW  - Humans
KW  - Leukocytes, Mononuclear
KW  - drug effects
KW  - Male
KW  - Middle Aged
KW  - Mucin-1
KW  - Mucins
KW  - Neoplasm Metastasis
KW  - Prostate-Specific Antigen
KW  - Prostatic Neoplasms
KW  - drug therapy
KW  - Taxoids
KW  - Time Factors
KW  - Treatment Outcome
KW  - Vaccination
KW  - methods
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Intramural
UR  - https://doi.org/10.1158/1078-0432.CCR-05-2059
ER  -